Austin, TX, USA, July 22, 2026 (GLOBE NEWSWIRE) -- Healthcare Foresights has published a new research report titled “AI in Drug Repurposing Market Size, Trends and Insights By Component (Software & Platforms, Services), By Technology (Machine Learning/Deep Learning, Natural Language Processing (NLP), Knowledge Graphs & Network-Based AI, Generative AI & Large Language Models (LLMs), Computer Vision), By Application (Oncology, Neurology, Cardiology, Infectious Diseases, Rare & Orphan Diseases, Other), and By Region - Global Industry Overview, Statistical Data, Competitive Analysis, Share, Outlook, and Forecast 2026 – 2035” in its research database.
“According to the latest research study, the demand of the global AI in Drug Repurposing Market size & share was valued at approximately USD 1.28 billion in 2025 and is expected to reach USD 1.51 billion in 2026 and is expected to reach a value of around USD 10.56 billion by 2035, at a compound annual growth rate (CAGR) of about 23.4% during the forecast period 2026 to 2035.”
Click Here to Access a Free Sample Report of the Global AI in Drug Repurposing Market @ https://www.healthcareforesights.com/request-sample?reportId=1111
![Healthcare Foresights has published a new research report titled “AI in Drug Repurposing Market Size, Trends and Insights By Component (Software & Platforms, Services), By Technology (Machine Learning/Deep Learning, Natural Language Processing (NLP), Knowledge Graphs & Network-Based AI, Generative AI & Large Language Models (LLMs), Computer Vision), By Application (Oncology, Neurology, Cardiology, Infectious Diseases, Rare & Orphan Diseases, Other), and By Region - Global Industry Overview, Statistical Data, Competitive Analysis, Share, Outlook, and Forecast 2026 – 2035” in its research database. “According to the latest research study, the demand of global AI in Drug Repurposing Market size & share was valued at approximately USD 1.28 Billion in 2025 and is expected to reach USD 1.51 Billion in 2026 and is expected to reach a value of around USD 10.56 Billion by 2035, at a compound annual growth rate (CAGR) of about 23.4% during the forecast period 2026 to 2035.” Click Here to Access a Free Sample Report of the Global AI in Drug Repurposing Market @ https://www.healthcareforesights.com/request-sample?reportId=1111 AI in Drug Repurposing Market Revenue and Trends The AI in Drug Repurposing Market is a substantial part of the global healthcare & pharmaceuticals industry and it's primarily driven by the growing need for the drug discovery acceleration and cost reduction. With the prevalence of rare diseases and chronic diseases becoming higher, the demand for swift and effective identification of existing drugs for the purpose of their use in new treatment areas is growing. AI-powered platforms allow researchers to delve into large amounts of data, predict the success rate of certain drug candidates and identify potential drug targets more effectively, and thereby enhancing success rates. The integration of AI with clinical trial data, biomedical data and real-world data is further empowering the decision-making and streamlining of drug repurposing procedures. Innovation in technology, rise in funding for AI-driven solutions, and increased collaborations between pharmaceutical and technology companies will likely escalate the market growth to a new level. The market growth is further influenced by favorable regulatory environments and an increasing shift toward personalized medicine. Request a Customized Copy of the AI in Drug Repurposing Market Report @ https://www.healthcareforesights.com/request-customization?reportId=1111 Which have been the major drivers behind the huge growth of the AI in Drug Repurposing Market? The AI in Drug Repurposing Market is mainly fueled by growing needs of decreasing drug discovery period and development costs. With growing instances of chronic, rare and infectious diseases, a great need for discovery of an effective therapy at a greater pace has led to an increase in the AI market to help in analysis of huge data of biological and clinical parameters. The new applications of already known drugs can be efficiently found with more precision and accuracy than previously before by using artificial intelligence. Also, the development of an extensive collaboration between big pharmaceutical and technology firms, along with increasing use of data driven approach will lead to increase in the market Also, technological advancement with in the field of machine learning, big data, clinical and real world data analysis are increasing the functionalities of the drug repurposing platform. With increasing investment on artificial intelligence based healthcare system, regulatory guidelines, and a paradigm shift towards a data-centric and precision-medicine approach, these are increasing the demand. The ever growing development in artificial intelligence algorithms, increasing healthcare infrastructure with particularly a boost in developing nations is expected to provide good growth in long term. (A free sample of the AI in Drug Repurposing report is available upon request; please contact us for more information.) Our Free Sample Report Consists of the following: • The updated report for 2026 includes an introduction, an overview, and an in-depth industry analysis. • Provide detailed chapter-by-chapter guidance on the Request. • Updated Regional Analysis with a Graphical Representation of Size, Share, and Trends for the Year 2026 • Includes Tables and figures have been updated. • The most recent version of the report includes the Top Market Players, their Business Strategies, Sales Volume, and Revenue Analysis Request a Customized Copy of the AI in Drug Repurposing Market Report @ https://www.healthcareforesights.com/reports/ai-in-drug-repurposing-market Segment Insight By Component Software & Platform dominates the AI in Drug Repurposing market share since they serve as the backbone of AI driven drug discovery through enabling integration of data, developing predictive models and identifying potential repurposing of existing drugs. These platforms are extensively adopted by pharma and biotech companies, resulting in reduced cost and rapid drug development. The Services market also registers robust growth and is attributed to rise in demand for consulting, implementation, and support services required for smooth integration and adoption of AI solutions into drug repurposing processes. By Technology Machine Learning Algorithms accounts for the largest share in AI in Drug Repurposing market share with a strong capability to analyze huge volumes of data and identify trends, enabling development of accurate predictive models. NLP is also anticipated to witness significant growth since it plays a pivotal role in extracting relevant information from the unstructured data, thus improving decision making. By Application The oncology sector held the largest market share owing to the higher incidence of cancer globally and thus the dire need to discover novel therapeutics at faster rates. Neurology and Cardiology sector hold significant share as there is a significant increase in cases of these diseases. Infectious Diseases sector is witnessing rapid growth post the global health crisis outbreak. Rare & Orphan Diseases segment is expected to be the fastest growing sector owing to less number of alternatives available and cost efficient development processes by AI whereas the other applications follow a consistent growth trend. Request a Customized Copy of the AI in Drug Repurposing Market Report @ https://www.healthcareforesights.com/reports/ai-in-drug-repurposing-market Key questions answered in this report: • What is the size of the AI in Drug Repurposing market, and what is its expected growth rate? • What are the primary driving factors that push the AI in Drug Repurposing market forward? • What are the AI in Drug Repurposing Industry's top companies? • What are the different categories that the AI in Drug Repurposing Market caters to? • What will be the fastest-growing segment or region? • In the value chain, what role do essential players play? • What is the procedure for getting a free copy of the AI in Drug Repurposing market sample report and company profiles? Buy Now the AI in Drug Repurposing Market Report @ https://www.healthcareforesights.com/checkout/1111 Key Offerings: • Market Share, Size & Forecast by Revenue | 2026−2035 • Market Dynamics – Growth Drivers, Restraints, Investment Opportunities, and Leading Trends • Market Segmentation – A detailed analysis by Types of Services, by End-User Services, and by regions • Competitive Landscape – Top Key Vendors and Other Prominent Vendors Buy this Premium AI in Drug Repurposing Research Report | Fast Delivery Available - [220+ Pages] @ https://www.healthcareforesights.com/reports/ai-in-drug-repurposing-market By Region North America accounted for the highest market share owing to superior healthcare infrastructure and strong adoption rate of technology and proliferation of pharmaceutical and biotech companies. The Europe follows with a steady growth rate due to growing investments and initiatives to facilitate the use of AI in healthcare sector. The Asia Pacific is poised for the fastest growth rate owing to booming investments in healthcare, increasing adoption of AI, and flourishing pharmaceutical sector of countries like China and India. Latin America and Middle East & Africa are estimated to grow at a moderate growth rate owing to the upgradation of health care infrastructure and awareness level of AI based solution development in the respective regions. Request a Customized Copy of the AI in Drug Repurposing Market Report @ https://www.healthcareforesights.com/reports/ai-in-drug-repurposing-market We customize your report to align with your specific research requirements. Inquire with our sales team about customizing your report.) Still Looking for More Information? Do you want data for inclusion in magazines, case studies, research papers, or media? Email Directly Here with Detailed Information: support@healthcareforesights.com Browse the full “AI in Drug Repurposing Market Size, Trends and Insights By Component (Software & Platforms, Services), By Technology (Machine Learning/Deep Learning, Natural Language Processing (NLP), Knowledge Graphs & Network-Based AI, Generative AI & Large Language Models (LLMs), Computer Vision), By Application (Oncology, Neurology, Cardiology, Infectious Diseases, Rare & Orphan Diseases, Other), and By Region - Global Industry Overview, Statistical Data, Competitive Analysis, Share, Outlook, and Forecast 2026 – 2035” Report at https://www.healthcareforesights.com/reports/ai-in-drug-repurposing-market Report Scope Feature of the Report Details Market Size in 2026 USD 1.51 billion Projected Market Size in 2035 USD 10.56 billion Market Size in 2025 USD 1.28 billion CAGR Growth Rate 23.4% CAGR Base Year 2025 Forecast Period 2026-2035 Key Segment By Component, Technology, Application and Region Report Coverage Revenue Estimation and Forecast, Company Profile, Competitive Landscape, Growth Factors and Recent Trends Regional Scope North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America Buying Options Request tailored purchasing options to fulfil your requirements for research. Recent Developments • In January 2024 BioXcel Therapeutics Inc announced it would further invest in its AI driven drug repurposing platform, aiming to boost machine learning functions and clinical data incorporation for accelerated new therapeutic area discovery and a reduction in drug development efficiency. Click Here to Access a Free Sample Report of the Global AI in Drug Repurposing Market @ https://www.healthcareforesights.com/reports/ai-in-drug-repurposing-market Spectacular Deals • Comprehensive coverage • Maximum number of market tables and figures • The subscription-based option is offered. • Best price guarantee • Free 35% or 60 hours of customization. • Free post-sale service assistance. • 25% discount on your next purchase. • Service guarantees are available. • A personalized market brief by the author. Browse More Related Reports: Digital Transformation in Healthcare Market eClinical Solutions Market Blood Bank Information System Market Colloids Blood Plasma Market Medical Simulation Market Laboratory Information System Market Healthcare Mobility Solutions Market AI Oncology Vibe CT Scanners Market Virtual Healthcare Delivery Market Life Sciences Next-Generation Consumer Engagement Platforms Market Healthcare Discount Plan Market List of the prominent players in the AI in Drug Repurposing Market: • BostonGene Corporation • BenevolentAI • Innophore • Delta4.ai • BioXcel Therapeutics Inc. • BullFrog AI Holdings Inc. • Graphwise • Owkin Inc • Insilico Medicine • Healx. • Others The AI in Drug Repurposing Market is segmented as follows: By Component • Software & Platforms • Services By Technology • Machine Learning/Deep Learning • Natural Language Processing (NLP) • Knowledge Graphs & Network-Based AI • Generative AI & Large Language Models (LLMs) • Computer Vision By Application • Oncology • Neurology • Cardiology • Infectious Diseases • Rare & Orphan Diseases • Other Click Here to Get a Free Sample Report of the Global AI in Drug Repurposing Market @ https://www.healthcareforesights.com/reports/ai-in-drug-repurposing-market Regional Coverage: North America • U.S. • Canada • Mexico • Rest of North America Europe • Germany • France • U.K. • Russia • Italy • Spain • Netherlands • Rest of Europe Asia Pacific • China • Japan • India • New Zealand • Australia • South Korea • Taiwan • Rest of Asia Pacific The Middle East & Africa • Saudi Arabia • UAE • Egypt • Kuwait • South Africa • Rest of the Middle East & Africa Latin America • Brazil • Argentina • Rest of Latin America This AI in Drug Repurposing Market Research/Analysis Report Contains Answers to the following Questions. • What Developments Are Going On in That Technology? Which Trends Are Causing These Developments? • Who Are the Global Key Players in This AI in Drug Repurposing Market? What are the company profiles, product information, and contact details for these key players? • What Was the Global Market Status of the AI in Drug Repurposing Market? What Was the Capacity, Production Value, Cost, and PROFIT of the AI in Drug Repurposing Market? • What Is the Current Market Status of the AI in Drug Repurposing Industry? What's the market's competition in this industry, both company-wise and country-wise? What's Market Analysis of AI in Drug Repurposing Market by Considering Applications and Types? • What Are Projections of the Global AI in Drug Repurposing Industry Considering Capacity, Production, and Production Value? What Will Be the Estimation of Cost and Profit? What Will Be Market Share, Supply, and Consumption? What about imports and exports? • What is a AI in Drug Repurposing market chain analysis of upstream raw materials and downstream industries? • What is the economic impact on the AI in Drug Repurposing industry? What are Global Macroeconomic Environment Analysis Results? What Are Global Macroeconomic Environment Development Trends? • What Are the Market Dynamics of the AI in Drug Repurposing Market? What Are Challenges and Opportunities? • What Should Be Entry Strategies, Countermeasures to Economic Impact, and Marketing Channels for AI in Drug Repurposing Industry? Click Here to Access a Free Sample Report of the Global AI in Drug Repurposing Market @ https://www.healthcareforesights.com/reports/ai-in-drug-repurposing-market Reasons to Purchase AI in Drug Repurposing Market Report • AI in Drug Repurposing Market Report provides qualitative and quantitative analysis of the market based on segmentation involving economic and non-economic factors. • AI in Drug Repurposing The Market report outlines market value (USD) data for each segment and sub-segment. • This report indicates the region and segment expected to witness the fastest growth and dominate the market. • AI in Drug Repurposing Market Analysis by geography highlights the consumption of the product/service in the region and indicates the factors affecting the market within each region. • The competitive landscape incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled. • Extensive company profiles comprise a company overview, company insights, product benchmarking, and SWOT analysis for the major market players. • Recent developments, including growth opportunities and drivers, as well as challenges and restraints in both emerging and developed regions, shape the industry's current and future market outlook. • AI in Drug Repurposing Market: Includes in-depth market analysis from various perspectives through Porter's five forces analysis and offers an overview of the market through the value chain. Reasons for the Research Report • The study provides a thorough overview of the global AI in Drug Repurposing market. Compare your performance to that of the market as a whole. • Aim to maintain competitiveness while innovations from established leaders drive market growth. Buy this Premium AI in Drug Repurposing Research Report | Fast Delivery Available - [220+ Pages] @ https://www.healthcareforesights.com/reports/ai-in-drug-repurposing-market What does the report include? • Drivers, restrictions, and opportunities are among the qualitative elements covered in the worldwide AI in Drug Repurposing market analysis. • The report covers the competitive environment of current and potential participants in the AI in Drug Repurposing market, along with their strategic product development ambitions. • This study conducts a qualitative and quantitative analysis of the AI in Drug Repurposing market based on the component, application, and industry vertical. Additionally, the report provides comparable data for the key regions. • The report provides actual market sizes and forecasts for each segment mentioned above. Who should buy this report? • Participants and stakeholders worldwide AI in Drug Repurposing market should find this report useful. The research will be useful to all market participants in the AI in Drug Repurposing industry. • Managers in the AI in Drug Repurposing sector are interested in publishing up-to-date and projected data about the worldwide AI in Drug Repurposing market. • Governmental agencies, regulatory bodies, decision-makers, and organizations want to invest in AI in Drug Repurposing products' market trends. • Analysts, researchers, educators, strategy managers, and government organizations seek market insights to develop plans. Request a Customized Copy of the AI in Drug Repurposing Market Report @ https://www.healthcareforesights.com/reports/ai-in-drug-repurposing-market About Healthcare Foresights: Healthcare Foresights is a market research and advisory company delivering business insights and market research reports to large, small, and medium-scale enterprises. We assist clients with strategies and business policies and regularly work towards achieving sustainable growth in their respective domains. Healthcare Foresights is a one-stop solution for data collection and investment advice. Our company's expert analysis digs out essential factors that help us understand the significance and impact of market dynamics. The professional experts advise clients on aspects such as strategies for future estimation, forecasting, opportunities to grow, and consumer surveys. Follow Us: LinkedIn | Twitter | Facebook | Instagram Contact Us: Frank Gittens CMI Consulting LLC 701 Tillery Street Unit 12-1333 Austin, Texas 78702 United States USA: +1 737-734-2707 APAC: +91 20 46022736 WhatsApp No : +1 801 639 9061 Email: support@healthcareforesights.com Blog: https://www.healthcareforesights.com/ Buy this Premium AI in Drug Repurposing Research Report | Fast Delivery Available - [220+ Pages] @ https://www.healthcareforesights.com/reports/ai-in-drug-repurposing-market](https://ml.globenewswire.com/Resource/Download/feda6faa-217c-4138-af44-3bcf069c3df4/ai-in-drug-repurposing-market-size-2025-to-2035-usd-billion-.webp)
AI in Drug Repurposing Market Revenue and Trends
The AI in the drug repurposing market is a substantial part of the global healthcare & pharmaceuticals industry and it's primarily driven by the growing need for drug discovery acceleration and cost reduction. With the prevalence of rare diseases and chronic diseases becoming higher, the demand for swift and effective identification of existing drugs for the purpose of their use in new treatment areas is growing. AI-powered platforms allow researchers to delve into large amounts of data, predict the success rate of certain drug candidates and identify potential drug targets more effectively, thereby enhancing success rates.
The integration of AI with clinical trial data, biomedical data and real-world data is further empowering the decision-making and streamlining of drug repurposing procedures. Innovation in technology, rise in funding for AI-driven solutions, and increased collaborations between pharmaceutical and technology companies will likely escalate the market growth to a new level. Favorable regulatory environments and an increasing shift toward personalized medicine further influence market growth.
Request a Customized Copy of the AI in Drug Repurposing Market Report @ https://www.healthcareforesights.com/request-customization?reportId=1111
Which have been the major drivers behind the huge growth of the AI in Drug Repurposing Market?
The AI in the drug repurposing market is primarily driven by the increasing need to reduce the drug discovery period and development costs. With growing instances of chronic, rare, and infectious diseases, a great need for the discovery of an effective therapy at a greater pace has led to an increase in the AI market to help in the analysis of large amounts of biological and clinical data.
Artificial intelligence now enables the discovery of new applications for already known drugs with greater precision and accuracy than was possible before. Also, the development of an extensive collaboration between big pharmaceutical and technology firms, along with increasing use of data driven approach will lead to increase in the market
Also, technological advancements within the fields of machine learning, big data, and clinical and real world data analysis are increasing the functionalities of the drug repurposing platform. With increasing investment in an artificial intelligence-based healthcare system, regulatory guidelines, and a paradigm shift towards a data-centric and precision medicine approach, these factors are driving demand. The ever-growing development in artificial intelligence algorithms and increasing healthcare infrastructure with a particular boost in developing nations is expected to provide good growth in the long term.
(A free sample of the AI in Drug Repurposing report is available upon request; please contact us for more information.)
Our Free Sample Report Consists of the following:
- The updated report for 2026 includes an introduction, an overview, and an in-depth industry analysis.
- Provide detailed chapter-by-chapter guidance on the Request.
- Updated Regional Analysis with a Graphical Representation of Size, Share, and Trends for the Year 2026.
- Includes Tables and figures have been updated.
- The most recent version of the report includes the Top Market Players, their Business Strategies, Sales Volume, and Revenue Analysis
Request a Customized Copy of the AI in Drug Repurposing Market Report @ https://www.healthcareforesights.com/reports/ai-in-drug-repurposing-market
Segment Insight
By Component
Software & Platform dominates the AI in Drug Repurposing market share since they serve as the backbone of AI-driven drug discovery through enabling integration of data, developing predictive models, and identifying potential repurposing of existing drugs. Pharma and biotech companies extensively adopt these platforms, which reduces costs and accelerates drug development. The Services market also registers robust growth and is attributed to the rise in demand for consulting, implementation, and support services required for smooth integration and adoption of AI solutions into drug repurposing processes.
By Technology
Machine learning algorithms hold the largest share in the AI drug repurposing market due to their strong capability to analyze vast amounts of data and identify trends, which enables the development of accurate predictive models. NLP is also expected to see significant growth, as it plays a pivotal role in extracting relevant information from unstructured data and thus improving decision-making.
By Application
The oncology sector held the largest market share owing to the higher incidence of cancer globally and thus the dire need to discover novel therapeutics at faster rates. The neurology and cardiology sectors hold a significant share as there is a significant increase in cases of these diseases. The infectious diseases sector is witnessing rapid growth post the global health crisis outbreak. The Rare & Orphan Diseases segment is expected to be the fastest growing sector owing to the lower number of alternatives available and cost-efficient development processes by AI, whereas the other applications follow a consistent growth trend.
Request a Customized Copy of the AI in Drug Repurposing Market Report @ https://www.healthcareforesights.com/reports/ai-in-drug-repurposing-market
Key questions answered in this report:
- What is the size of the AI in the drug repurposing market, and what is its expected growth rate?
- What are the primary driving factors that push the AI in the drug repurposing market forward?
- What are the top companies in the AI in the drug repurposing industry?
- What are the different categories that the AI in the drug repurposing market caters to?
- What will be the fastest-growing segment or region?
- In the value chain, what role do key players play?
- What is the procedure for obtaining a free copy of the AI in Drug Repurposing market sample report and company profiles?
Buy Now the AI in Drug Repurposing Market Report @ https://www.healthcareforesights.com/checkout/1111
Key Offerings:
- Market Share, Size & Forecast by Revenue | 2026−2035
- Market Dynamics – Growth Drivers, Restraints, Investment Opportunities, and Leading Trends
- Market Segmentation – A detailed analysis by Types of Services, by End-User Services, and by regions
- Competitive Landscape – Top Key Vendors and Other Prominent Vendors
Buy this Premium AI in Drug Repurposing Research Report | Fast Delivery Available - [220+ Pages] @ https://www.healthcareforesights.com/reports/ai-in-drug-repurposing-market
By Region
North America accounted for the highest market share owing to superior healthcare infrastructure and strong adoption rates of technology and proliferation of pharmaceutical and biotech companies. The Europe follows with a steady growth rate due to growing investments and initiatives to facilitate the use of AI in healthcare sector. The Asia Pacific is poised for the fastest growth rate owing to booming investments in healthcare, increasing adoption of AI, and the flourishing pharmaceutical sector of countries like China and India. Latin America and the Middle East & Africa are estimated to grow at a moderate growth rate owing to the upgradation of health care infrastructure and the awareness level of AI-based solution development in the respective regions.
Request a Customized Copy of the AI in Drug Repurposing Market Report @ https://www.healthcareforesights.com/reports/ai-in-drug-repurposing-market
We customize your report to align with your specific research requirements. Inquire with our sales team about customizing your report.)
Still Looking for More Information? Do you want data for inclusion in magazines, case studies, research papers, or media?
Email Directly Here with Detailed Information: support@healthcareforesights.com
Browse the full “AI in Drug Repurposing Market Size, Trends and Insights By Component (Software & Platforms, Services), By Technology (Machine Learning/Deep Learning, Natural Language Processing (NLP), Knowledge Graphs & Network-Based AI, Generative AI & Large Language Models (LLMs), Computer Vision), By Application (Oncology, Neurology, Cardiology, Infectious Diseases, Rare & Orphan Diseases, Other), and By Region - Global Industry Overview, Statistical Data, Competitive Analysis, Share, Outlook, and Forecast 2026 – 2035” Report at https://www.healthcareforesights.com/reports/ai-in-drug-repurposing-market
Report Scope
| Feature of the Report | Details |
| Market Size in 2026 | USD 1.51 billion |
| Projected Market Size in 2035 | USD 10.56 billion |
| Market Size in 2025 | USD 1.28 billion |
| CAGR Growth Rate | 23.4% CAGR |
| Base Year | 2025 |
| Forecast Period | 2026-2035 |
| Key Segment | By Component, Technology, Application and Region |
| Report Coverage | Revenue Estimation and Forecast, Company Profile, Competitive Landscape, Growth Factors and Recent Trends |
| Regional Scope | North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America |
| Buying Options | Request tailored purchasing options to fulfil your requirements for research. |
Recent Developments
- In January 2024, BioXcel Therapeutics Inc. announced it would invest more in its AI-driven drug repurposing platform, aiming to improve machine learning functions and clinical data incorporation to speed up new therapeutic area discovery and make drug development more efficient.
Click Here to Access a Free Sample Report of the Global AI in Drug Repurposing Market @ https://www.healthcareforesights.com/reports/ai-in-drug-repurposing-market
Spectacular Deals
- Comprehensive coverage.
- Maximum number of market tables and figures.
- The subscription-based option is offered.
- Best price guarantee.
- Free 35% or 60 hours of customization.
- Free post-sale service assistance.
- 25% discount on your next purchase.
- Service guarantees are available.
- A personalized market brief by the author.
Browse More Related Reports:
Digital Transformation in Healthcare Market
Blood Bank Information System Market
Laboratory Information System Market
Healthcare Mobility Solutions Market
AI Oncology Vibe CT Scanners Market
Virtual Healthcare Delivery Market
Life Sciences Next-Generation Consumer Engagement Platforms Market
Healthcare Discount Plan Market
List of the prominent players in the AI in Drug Repurposing Market:
- BostonGene Corporation
- BenevolentAI
- Innophore
- Delta4.ai
- BioXcel Therapeutics Inc.
- BullFrog AI Holdings Inc.
- Graphwise
- Owkin Inc
- Insilico Medicine
- Healx.
- Others
The AI in Drug Repurposing Market is segmented as follows:
By Component
- Software & Platforms
- Services
By Technology
- Machine Learning/Deep Learning
- Natural Language Processing (NLP)
- Knowledge Graphs & Network-Based AI
- Generative AI & Large Language Models (LLMs)
- Computer Vision
By Application
- Oncology
- Neurology
- Cardiology
- Infectious Diseases
- Rare & Orphan Diseases
- Other
Click Here to Get a Free Sample Report of the Global AI in Drug Repurposing Market @ https://www.healthcareforesights.com/reports/ai-in-drug-repurposing-market
Regional Coverage:
North America
- U.S.
- Canada
- Mexico
- Rest of North America
Europe
- Germany
- France
- U.K.
- Russia
- Italy
- Spain
- Netherlands
- Rest of Europe
Asia Pacific
- China
- Japan
- India
- New Zealand
- Australia
- South Korea
- Taiwan
- Rest of Asia Pacific
The Middle East & Africa
- Saudi Arabia
- UAE
- Egypt
- Kuwait
- South Africa
- Rest of the Middle East & Africa
Latin America
- Brazil
- Argentina
- Rest of Latin America
This AI in Drug Repurposing Market Research/Analysis Report Contains Answers to the following Questions.
- What Developments Are Going On in That Technology? Which Trends Are Causing These Developments?
- Who are the global key players in the AI drug repurposing market? What are the company profiles, product information, and contact details for these key players?
- What was the global market status of AI in the drug repurposing market? What were the capacity, production value, cost, and PROFIT of the AI in the drug repurposing market?
- What Is the Current Market Status of AI in the Drug Repurposing Industry? What's the market's competition in this industry, both company-wise and country-wise? What's the market analysis of AI in the drug repurposing market by considering applications and types?
- What are projections of global AI in the drug repurposing industry considering capacity, production, and production value? What Will Be the Estimation of Cost and Profit? What Will Be the Market Share, Supply, and Consumption? What about imports and exports?
- What is an AI in the drug repurposing market chain analysis of upstream raw materials and downstream industries?
- What is the economic impact on AI in the drug repurposing industry? What are global macroeconomic environment analysis results? What Are Global Macroeconomic Environment Development Trends?
- What Are the Market Dynamics of AI in the Drug Repurposing Market? What Are Challenges and Opportunities?
- What Should Be Entry Strategies, Countermeasures to Economic Impact, and Marketing Channels for AI in the Drug Repurposing Industry?
Click Here to Access a Free Sample Report of the Global AI in Drug Repurposing Market @ https://www.healthcareforesights.com/reports/ai-in-drug-repurposing-market
Reasons to Purchase AI in Drug Repurposing Market Report
- The AI in Drug Repurposing Market Report provides qualitative and quantitative analysis of the market based on segmentation involving economic and non-economic factors.
- AI in Drug Repurposing The market report outlines market value (USD) data for each segment and sub-segment.
- This report indicates the region and segment expected to witness the fastest growth and dominate the market.
- AI in Drug Repurposing Market Analysis by geography highlights the consumption of the product/service in the region and indicates the factors affecting the market in each region.
- The competitive landscape incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled.
- Extensive company profiles comprise a company overview, company insights, product benchmarking, and SWOT analysis for the major market players.
- Recent developments, including growth opportunities and drivers, as well as challenges and restraints in both emerging and developed regions, shape the industry's current and future market outlook.
- AI in Drug Repurposing Market: Includes in-depth market analysis from various perspectives through Porter's five forces analysis and offers an overview of the market through the value chain.
Reasons for the Research Report
- The study provides a thorough overview of the global AI in drug repurposing market. Compare your performance to that of the market as a whole.
- Aim to maintain competitiveness while innovations from established leaders drive market growth.
Buy this Premium AI in Drug Repurposing Research Report | Fast Delivery Available - [220+ Pages] @ https://www.healthcareforesights.com/reports/ai-in-drug-repurposing-market
What does the report include?
- Drivers, restrictions, and opportunities are among the qualitative elements covered in the worldwide AI in drug repurposing market analysis.
- The report covers the competitive environment of current and potential participants in the AI in drug repurposing market, along with their strategic product development ambitions.
- This study conducts a qualitative and quantitative analysis of the AI in the drug repurposing market based on the component, application, and industry vertical. Additionally, the report provides comparable data for the key regions.
- The report provides actual market sizes and forecasts for each segment mentioned above.
Who should buy this report?
- Participants and stakeholders in the worldwide AI in Drug Repurposing market should find this report useful. The research will be useful to all market participants in the AI in drug repurposing industry.
- Managers in the AI in Drug Repurposing sector are interested in publishing up-to-date and projected data about the worldwide AI in drug repurposing market.
- Governmental agencies, regulatory bodies, decision-makers, and organizations want to invest in AI in drug repurposing products' market trends.
- Analysts, researchers, educators, strategy managers, and government organizations seek market insights to develop plans.
Request a Customized Copy of the AI in Drug Repurposing Market Report @ https://www.healthcareforesights.com/reports/ai-in-drug-repurposing-market
About Healthcare Foresights:
Healthcare Foresights is a market research and advisory company delivering business insights and market research reports to large, small, and medium-scale enterprises. We assist clients with strategies and business policies, regularly working towards sustainable growth in their respective domains.
Healthcare Foresights is a one-stop solution for data collection and investment advice. Our company's expert analysis digs out essential factors that help us understand the significance and impact of market dynamics. The professional experts advise clients on aspects such as strategies for future estimation, forecasting, opportunities to grow, and consumer surveys.
Follow Us: LinkedIn | Twitter | Facebook | Instagram
Contact Us:
Frank Gittens
CMI Consulting LLC
701 Tillery Street Unit 12-1333
Austin, Texas 78702
United States
USA: +1 737-734-2707
APAC: +91 20 46022736
Email: support@healthcareforesights.com
Blog: https://www.healthcareforesights.com/
Buy this Premium AI in Drug Repurposing Research Report | Fast Delivery Available - [220+ Pages] @ https://www.healthcareforesights.com/reports/ai-in-drug-repurposing-market
